trial

Evaluation and Validation of Social Cognition Battery to Characterize Schizophrenic Patients Functioning

NCTId NCT02901015
as of 2026-07-01
Add to landscapeMonitor thisAsk about this
at a glance
— · Completed
Enrollment 173 (actual)
Sponsored by Versailles Hospital
Primary completion 2017-06
Synthesized from structured facts only — each point cited above.

Design & status

Phase
—
Status
Completed
Enrollment
173 (actual)
Study type
Interventional
Allocation
Randomized
Model
Parallel
Masking
None
Start
2013-04
Primary completion
2017-06
Eligibility
ALL · 18 Years · 65 Years

Interventions & indications

Drugs
Assessment battery AAssessment battery B

Sponsors

Versailles HospitalLead Sponsor

Sites

8 total
Clermont-Ferrand, FranceColombes, FranceCréteil, FranceLe Chesnay, FranceMarseille, FranceMontpellier, FranceSaint Egrève, FranceStrasbourg, France

Facts & assertions

4 sourced
Enrollment
173
Phase
NA
Primary Completion Date
2017-06
Status
COMPLETED
relationships
The graph out of here
drug
Assessment battery A
drug
Assessment battery B
drug
lead_sponsor
Versailles Hospital
company
indication
Schizophrenia
indication
Schizophrenia
indication